In the framework of Rare Disease Day, join the European Brain Council’s 'Towards a Rare Brain Disease Ecosystem' event held in Brussels on 20 February 2025!

The European Journal of Neurology and the European Academy of Neurology are launching a new benefit to reward our most productive reviewers from January 2024 onwards.

We are excited to introduce a new competition, Your EAN Congress Story, giving you the chance to win free registration for the EAN Congress 2025 in Helsinki, Finland on 21-24 June 2025!

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Find out how to host EAN regional teaching events, designed to provide high-quality training to neurology residents and professionals in related specialties.

We are proud to support the International Day of Education by offering a range of eanCampus content to anyone with a myEAN account!

The next EAN Congress Masterclass in Vienna will explore the latest advancements in treatments on 28 March, on Innovative Treatments in Rare Neuroimmunological Disorders.

A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe.

EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved!

Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!

The Lancet Neurology highlights the urgent need to prioritise brain health in a new editorial, citing the Brain Health Mission as an example of positive initiatives aiming to promote brain health.  

Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.

The EAN is proud to host the European Brain Health Summit 2025 on 19 March, from 09:00 to 12:00 CET, both onsite in Brussels, and streaming live via EAN.org

Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors.

Take our EAN 2025 Congress Quiz for your chance to win free registration for the 11th Congress of the European Academy of Neurology!